These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 199477

  • 21. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 22. Plasma human chorionic gonadotropin, estrone, estradiol, estriol, progesterone, and 17 alpha-hydroxyprogesterone in human pregnancy. 3. Early normal pregnancy.
    Tulchinsky D, Hobel CJ.
    Am J Obstet Gynecol; 1973 Dec 01; 117(7):884-93. PubMed ID: 4759826
    [No Abstract] [Full Text] [Related]

  • 23. Persistent gestational trophoblastic disease after a diploid partial hydatidiform mole coexisting with a normal living fetus.
    Cheung NY, Ngan HY, Ghosh A.
    Int J Gynaecol Obstet; 1992 Jul 01; 38(3):238-9. PubMed ID: 1360430
    [No Abstract] [Full Text] [Related]

  • 24. Progesterone concentrations in the sera of patients with intact and aborted hydatidiform moles.
    Dawood MY.
    Am J Obstet Gynecol; 1974 Aug 01; 119(7):911-8. PubMed ID: 4366792
    [No Abstract] [Full Text] [Related]

  • 25. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ, Huang SC, Chow SN, Hsieh CY, Hsu HC.
    Br J Obstet Gynaecol; 1994 Apr 01; 101(4):330-4. PubMed ID: 8199080
    [Abstract] [Full Text] [Related]

  • 26. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK, Daunter B.
    Aust N Z J Obstet Gynaecol; 1980 Feb 01; 20(1):35-42. PubMed ID: 6248013
    [Abstract] [Full Text] [Related]

  • 27. [HCG in patients with hydatidiform mole or chorionepithelioma].
    Rjosk HK, Gokel JM, Holzmann K.
    Arch Gynecol; 1979 Jul 20; 228(1-4):667-8. PubMed ID: 485551
    [No Abstract] [Full Text] [Related]

  • 28. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
    Seki K, Uesato T, Kato K.
    Endocrinol Jpn; 1986 Oct 20; 33(5):727-33. PubMed ID: 3030714
    [Abstract] [Full Text] [Related]

  • 29. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN, Salem HT, Al-Ani AT, Chard T, Huang SC, Ouyang PC, Wei PY, Seppälä M.
    Am J Obstet Gynecol; 1981 Mar 15; 139(6):702-4. PubMed ID: 6971058
    [Abstract] [Full Text] [Related]

  • 30. Alpha-Subunit in sera of choriocarcinoma patients in remission.
    Quigley MM, Tyrey L, Hammond CB.
    J Clin Endocrinol Metab; 1980 Jan 15; 50(1):98-102. PubMed ID: 6243136
    [No Abstract] [Full Text] [Related]

  • 31. [Determination of low unit hCG Higonavis: application to the management of chorionic tumor].
    Tojo S, Kanazawa S, Maruo T, Mikami K, Sakagami A.
    Horumon To Rinsho; 1973 Nov 15; 21(11):1179-86. PubMed ID: 4360619
    [No Abstract] [Full Text] [Related]

  • 32. Progestogens in pregnancy.
    Vande Wiele RL, Husami N, Dyrenfurth I.
    Prog Clin Biol Res; 1976 Nov 15; 10():179-203. PubMed ID: 193130
    [No Abstract] [Full Text] [Related]

  • 33. Coexisting epithelioid trophoblastic tumor and choriocarcinoma of the uterus following a chemoresistant hydatidiform mole.
    Shen DH, Khoo US, Ngan HY, Ng TY, Chau MT, Xue WC, Cheung AN.
    Arch Pathol Lab Med; 2003 Jul 15; 127(7):e291-3. PubMed ID: 12823059
    [Abstract] [Full Text] [Related]

  • 34. [Evaluation of remission in trophoblastic disease as seen from serum hCG level (author's transl)].
    Hirashima N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May 15; 32(5):592-600. PubMed ID: 6263999
    [Abstract] [Full Text] [Related]

  • 35. Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast.
    Seppälä M, Wahlström T, Bohn H.
    Int J Cancer; 1979 Jul 15; 24(1):6-10. PubMed ID: 225283
    [No Abstract] [Full Text] [Related]

  • 36. Plasma androstenedione (A) and dihydrotesto-terone (DHT) in patients with trophoblastic disease and the effect of chemotherapy and oophorectomy.
    Samaan NA, Smith JP, Rutledge FN.
    Gynecol Invest; 1973 Jul 15; 4(5-6):237-42. PubMed ID: 4373314
    [No Abstract] [Full Text] [Related]

  • 37. Serum prolactin levels and immunohistochemical localization of prolactin in trophoblastic disease.
    Ranta T, Wahlström T, Rutanen EM, Stenman UH, Seppälä M.
    Acta Pathol Microbiol Scand A; 1981 May 15; 89(3):235-9. PubMed ID: 6274140
    [Abstract] [Full Text] [Related]

  • 38. ABO blood group in patients with malignant trophoblastic disease.
    Sasaki K, Hata H, Nakano R.
    Gynecol Obstet Invest; 1985 May 15; 20(1):23-6. PubMed ID: 2995210
    [Abstract] [Full Text] [Related]

  • 39. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH, Cannon W, Benedet JL, Boyes DA.
    Am J Obstet Gynecol; 1977 Apr 01; 127(7):711-2. PubMed ID: 557901
    [Abstract] [Full Text] [Related]

  • 40. [Choriocarcinoma in a male patient with circulating thyrotropic activity and adrenocortical hyperfunction].
    Orgiazzi J, Rousset B, Cosentino C, Saez J, Tourniaire J.
    Ann Endocrinol (Paris); 1972 Apr 01; 33(3):272-3. PubMed ID: 4346619
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.